Standard Investments LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 88 filers reported holding REVANCE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
Standard Investments LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2015$992,000
+22.3%
47,8460.0%0.06%
+41.9%
Q4 2014$811,000
-12.3%
47,8460.0%0.04%
-12.2%
Q3 2014$925,000
+7.6%
47,846
+89.1%
0.05%
-9.3%
Q2 2014$860,000
+7.9%
25,3000.0%0.05%
-28.0%
Q1 2014$797,00025,3000.08%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,592,047$121,230,00021.92%
Rhenman & Partners Asset Management AB 220,000$5,808,0000.83%
ArrowMark Colorado Holdings LLC 2,045,862$54,011,0000.67%
Vivo Capital, LLC 77,373$2,043,0000.52%
Ghost Tree Capital, LLC 89,295$2,357,0000.49%
ESSEX INVESTMENT MANAGEMENT CO LLC 124,932$3,298,0000.47%
Polar Capital LLP 1,296,371$34,220,0000.46%
SUFFOLK CAPITAL MANAGEMENT LLC 70,095$1,851,0000.24%
EAM Investors, LLC 33,897$895,0000.15%
PointState Capital LP 438,200$11,568,0000.13%
View complete list of REVANCE THERAPEUTICS INC shareholders